Literature DB >> 1185743

Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.

T D Kinsella, L Espinoza, F B Vasey.   

Abstract

Serum levels of C4, C3, IgG, IgM and IgA were measured by immunodiffusion in age matched groups of 48 sporadically encountered patients with ankylosing spondylitis, 56 with rheumatoid arthritis and 52 normal controls. Mean levels of C4 and IgA were significantly elevated in the sera of patients with sporadic ankylosing spondylitis, in comparison to normal controls. Mean IgA levels were also significantly elevated in 11 HL-A 27 positive patients with familial spondylitis but no such elevation was found in the sera of their healthy first-degree relatives with and without HL-A 27. The results of these studies suggest that humoral immune mechanisms may be involved in the pathophysiology of ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185743

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.

Authors:  H Hocini; S Iscaki; C Benlahrache; L Vitalis; X Chevalier; B Larget-Piet; J P Bouvet
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 3.  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Authors:  M L Stoll
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

4.  IgA-alpha 1 antitrypsin complexes in ankylosing spondylitis.

Authors:  G R Struthers; I V Lewin; D R Stanworth
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

5.  Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis.

Authors:  A Mackiewicz; M A Khan; T L Reynolds; S van der Linden; I Kushner
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

6.  Absence of IgA nephropathy in patients with ankylosing spondylitis.

Authors:  A J Swaak; I Frankfort; R S Menon; J M Pekelharing; O Planten
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Association of inflammation with raised serum IgA in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

8.  Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

9.  Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

Authors:  K M Sanders; A Hertzman; M R Escobar; B H Littman
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

10.  Detection of immune complexes in serum of patients with ankylosing spondylitis.

Authors:  V Corrigall; G S Panayi; A Unger; R N Poston; B D Williams
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.